According to lead author, Dr. Ian Bruce, at the University of Manchester, UK, the results are encouraging
A new study points to specific changes companies can make in clinical trials so that, in the future, clearer data can lead us closer to a cure.
A new study looked specifically at rates of hospitalization for serious infections among people with lupus.
Further studies may lead to interventions that improve the health outcomes of people with lupus.
A new research study by Foundation grantee Dr. Laurence Morel identifies a lupus related gene that affects adult mesenchymal stem cells. Read more.
Part of a new analysis from the ongoing Hopkins Lupus Cohort provides new knowledge that may help physicians make decisions about gradually reducing corticosteroid doses in people with lupus.
Jasvinder Singh, M.D., a prominent researcher in rheumatic disease, has been awarded a $1.5 million, three year grant from the Patient-Centered Outcomes Research Institute for a decision aid to help doctors and their African-American and Hispanic lupus patients with kidney disease choose the best treatment for each individual patient.
At a scientific symposium in San Francisco last month, some of the country’s foremost experts on lupus shared their insights about the current state of lupus clinical trial design. Read more.